GENEVA, Sept. 29 -- SEAGEN INC. (21823 30th Drive SEBothell, Washington 98021) filed a patent application (PCT/IB2025/052829) for "CD25 ANTIBODIES, ANTIBODY-DRUG CONJUGATES, AND USES THEREOF" on Mar 18, 2025. With publication no. WO/2025/196639, the details related to the patent application was published on Sep 25, 2025.
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Inventor(s): ABDELHAMED, Sherif (c/o Seagen Inc.21823 30th Drive SEBothell, Washington 98021), GARDAI, Shyra (c/o Seagen Inc.21823 30th Drive SEBothell, Washington 98021), LEVENGOOD, Matthew (c/o Seagen Inc.21823 30th Drive SEBothell, Washington ...